Suzanne Bezstarosti

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The Progress and Challenges of Implementing HLA Molecular Matching in Clinical Practice.

The Progress and Challenges of Implementing HLA Molecular Matching in Clinical Practice.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: April 01, 2025

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation.

Alemtuzumab Exposure and T Lymphocyte Depletion: A Population Pharmacokinetic-Pharmacodynamic Model of Alemtuzumab Induction Therapy for Kidney Transplantation.

Journal: Clinical pharmacology and therapeutics

Published: February 16, 2025

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

Journal: Frontiers in genetics

Published: May 21, 2024

Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.

Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.

Journal: HLA

Published: September 08, 2023

HLA antibody affinity determination: From HLA-specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum.

HLA antibody affinity determination: From HLA-specific monoclonal antibodies to donor HLA specific antibodies (DSA) in patient serum.

Journal: HLA

Published: December 30, 2022

HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.

HLA-DQ eplet mismatch load may identify kidney transplant patients eligible for tacrolimus withdrawal without donor-specific antibody formation after mesenchymal stromal cell therapy.

Journal: HLA

Published: October 17, 2022

Site-directed mutagenesis of HLA molecules reveals the functional epitope of a human HLA-A1/A36-specific monoclonal antibody.

Site-directed mutagenesis of HLA molecules reveals the functional epitope of a human HLA-A1/A36-specific monoclonal antibody.

Journal: HLA

Published: September 01, 2022

Left Atrial Structural and Functional Response in Kidney Transplant Recipients Treated With Mesenchymal Stromal Cell Therapy and Early Tacrolimus Withdrawal.

Left Atrial Structural and Functional Response in Kidney Transplant Recipients Treated With Mesenchymal Stromal Cell Therapy and Early Tacrolimus Withdrawal.

Journal: Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography

Published: July 20, 2022

Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study.

Cardiovascular Effects of Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Therapy With Early Tacrolimus Withdrawal in Renal Transplant Recipients: An Analysis of the Randomized TRITON Study.

Journal: Journal of the American Heart Association

Published: December 16, 2021

Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation.

Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation.

Journal: British journal of clinical pharmacology

Published: November 03, 2021

Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.

Implementation of molecular matching in transplantation requires further characterization of both immunogenicity and antigenicity of individual HLA epitopes.

Journal: Human immunology

Published: October 31, 2021

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Journal: Frontiers in immunology

Published: October 24, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026